Literature DB >> 30086414

The association of multimorbidity with healthcare expenditure among the elderly patients in Beijing, China.

He Chen1, Yao Chen2, Bin Cui3.   

Abstract

OBJECTIVES: To add evidence to the relationship between multimorbidity and healthcare expenditure.
METHODS: The study population comprised patients aged ≥60 in Beijing, covered by the Urban Employee Basic Medical Insurance (UEBMI) (N = 30,774). Multimorbidity was measured with 33 chronic conditions confirmed by doctors. Multivariate linear regression was performed.
RESULTS: The prevalence of multimorbidity was 82% among elderly patients in Beijing and was higher in older and female patients. About 95% of the healthcare expenditure on the 33 conditions was spent on multimorbid patients. In the multivariate analysis, after inclusion of demographic characteristics, disease severity, and health facility level, the expenditure increased significantly with the number of chronic conditions. After further including condition types, the coefficients of the number of conditions were much lower than those in previous models. The expenditure on patients with two and three conditions was 3.4 times (95% CI: 3.2-3.7) and 5.3 times (95% CI: 4.7-6.0) higher than that on patients with a single condition, respectively; however, the expenditure did not significantly increase after three conditions.
CONCLUSIONS: Multimorbidity is common among elderly patients in Beijing and consumes the majority of the healthcare resources. The health delivery system in China and other low- and middle-income countries needs to pay more attention to multimorbidity.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  China; Health insurance; Healthcare expenditure; Multimorbidity; Older persons; Urban

Mesh:

Year:  2018        PMID: 30086414     DOI: 10.1016/j.archger.2018.07.008

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  11 in total

1.  Prevalence and patterns of multimorbidity in chronic diseases in Guangzhou, China: a data mining study in the residents' health records system among 31 708 community-dwelling elderly people.

Authors:  Wei-Quan Lin; Le-Xin Yuan; Min-Ying Sun; Chang Wang; En-Min Liang; Yao-Hui Li; Lan Liu; Yun-Ou Yang; Di Wu; Guo-Zhen Lin; Hui Liu
Journal:  BMJ Open       Date:  2022-05-25       Impact factor: 3.006

2.  Multimorbidity patterns and associated factors in older Chinese: results from the China health and retirement longitudinal study.

Authors:  Quan Zhang; Xiao Han; Xinyi Zhao; Yue Wang
Journal:  BMC Geriatr       Date:  2022-06-01       Impact factor: 4.070

3.  Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.

Authors:  Ranjit Manchanda; Li Sun; Shreeya Patel; Olivia Evans; Janneke Wilschut; Ana Carolina De Freitas Lopes; Faiza Gaba; Adam Brentnall; Stephen Duffy; Bin Cui; Patricia Coelho De Soarez; Zakir Husain; John Hopper; Zia Sadique; Asima Mukhopadhyay; Li Yang; Johannes Berkhof; Rosa Legood
Journal:  Cancers (Basel)       Date:  2020-07-17       Impact factor: 6.639

4.  Associations between mental health disorder and management of physical chronic conditions in China: a pooled cross-sectional analysis.

Authors:  Zheng Zhang; Grace Sum; Vicky Mengqi Qin; Yang Zhao; Tilahun Nigatu Haregu; Brian Oldenburg; John Tayu Lee
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

5.  Medical costs and out-of-pocket expenditures associated with multimorbidity in China: quantile regression analysis.

Authors:  Yang Zhao; Rifat Atun; Kanya Anindya; Barbara McPake; Tiara Marthias; Tianxin Pan; Alexander van Heusden; Puhong Zhang; Nadila Duolikun; John Lee
Journal:  BMJ Glob Health       Date:  2021-02

6.  Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China.

Authors:  Li Sun; Bin Cui; Xia Wei; Zia Sadique; Li Yang; Ranjit Manchanda; Rosa Legood
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

7.  Impacts of multimorbidity on medication treatment, primary healthcare and hospitalization among middle-aged and older adults in China: evidence from a nationwide longitudinal study.

Authors:  Yang Zhao; Siqi Zhao; Lin Zhang; Tilahun Nigatu Haregu; Haipeng Wang
Journal:  BMC Public Health       Date:  2021-07-12       Impact factor: 3.295

8.  Patients with more comorbidities have better detection of chronic conditions, but poorer management and control: findings from six middle-income countries.

Authors:  Grace Sum; Gerald Choon-Huat Koh; Stewart W Mercer; Lim Yee Wei; Azeem Majeed; Brian Oldenburg; John Tayu Lee
Journal:  BMC Public Health       Date:  2020-01-06       Impact factor: 3.295

9.  Urban-rural disparity in prevalence of multimorbidity in China: a cross-sectional nationally representative study.

Authors:  Xiaochen Ma; Yu He; Jin Xu
Journal:  BMJ Open       Date:  2020-11-16       Impact factor: 2.692

10.  Multimorbidity of chronic non-communicable diseases in low- and middle-income countries: A scoping review.

Authors:  Fantu Abebe; Marguerite Schneider; Biksegn Asrat; Fentie Ambaw
Journal:  J Comorb       Date:  2020-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.